GGrantIndex
← Search

ADVL0214, A PHASE I STUDY OF SINGLE AGENT OSI-774 (TARCEVA) FOLLOWED BY OSI-77S

$879M01FY2007RRNIH

Baylor College Of Medicine, Houston TX

Investigators

Linked publications & trials

View original record on NIH RePORTER →